MX2016017321A - Combinacicones y metodos para el tratamiento de dolor neuropatico. - Google Patents
Combinacicones y metodos para el tratamiento de dolor neuropatico.Info
- Publication number
- MX2016017321A MX2016017321A MX2016017321A MX2016017321A MX2016017321A MX 2016017321 A MX2016017321 A MX 2016017321A MX 2016017321 A MX2016017321 A MX 2016017321A MX 2016017321 A MX2016017321 A MX 2016017321A MX 2016017321 A MX2016017321 A MX 2016017321A
- Authority
- MX
- Mexico
- Prior art keywords
- neuropathic pain
- treatment
- combinations
- methods
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presenta invención se relaciona con un método de tratamiento de dolor neuropático, que comprende co-administrar ácido alfa lipoico y pregabalina. La presente invención también proporciona una composición farmacéutica que comprende una combinación de ácido alfa lipoico y pregabalina. La composición farmacéutica de la presente invención es útil para el tratamiento de dolor neuropático.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/MX2016/000137 WO2018111060A1 (es) | 2016-12-14 | 2016-12-14 | Combinaciones y métodos para el tratamiento de dolor neuropático |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016017321A true MX2016017321A (es) | 2018-08-20 |
Family
ID=62559579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016017321A MX2016017321A (es) | 2016-12-14 | 2016-12-14 | Combinacicones y metodos para el tratamiento de dolor neuropatico. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12029727B2 (es) |
| EP (1) | EP3593795B1 (es) |
| BR (1) | BR112019012226A2 (es) |
| CA (1) | CA3047077C (es) |
| MX (1) | MX2016017321A (es) |
| WO (1) | WO2018111060A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102374820B1 (ko) * | 2020-11-04 | 2022-03-16 | 전남대학교병원 | 프레가발린 및 티아넵틴을 포함하는 신경병성 통증 치료용 약학적 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20072051A1 (it) | 2007-10-23 | 2009-04-24 | Chimico Internaz S P A In Brev | Composizione a base di pellet di acido lipoico |
| WO2014168228A1 (ja) * | 2013-04-12 | 2014-10-16 | マルホ株式会社 | 局所用組成物 |
| US20160058752A1 (en) | 2014-02-04 | 2016-03-03 | Afgin Pharma, Llc | Topical peripheral neuro-affective (tpna) therapy for neuropathic conditions |
-
2016
- 2016-12-14 CA CA3047077A patent/CA3047077C/en active Active
- 2016-12-14 WO PCT/MX2016/000137 patent/WO2018111060A1/es not_active Ceased
- 2016-12-14 US US16/469,277 patent/US12029727B2/en active Active
- 2016-12-14 MX MX2016017321A patent/MX2016017321A/es unknown
- 2016-12-14 BR BR112019012226-5A patent/BR112019012226A2/pt not_active Application Discontinuation
- 2016-12-14 EP EP16923959.7A patent/EP3593795B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3047077C (en) | 2024-01-02 |
| US12029727B2 (en) | 2024-07-09 |
| EP3593795A4 (en) | 2020-05-06 |
| WO2018111060A1 (es) | 2018-06-21 |
| US20200101043A1 (en) | 2020-04-02 |
| EP3593795A1 (en) | 2020-01-15 |
| EP3593795B1 (en) | 2025-11-12 |
| CA3047077A1 (en) | 2018-06-21 |
| BR112019012226A2 (pt) | 2019-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201792496A1 (ru) | Способы лечения воспаления или нейропатической боли | |
| SV2018005709A (es) | 3-azabiciclo[3.1.0]hexanos sustituidos como inhibidores de cetohexoquinasa | |
| CL2019001066A1 (es) | Sal de (s)-csa de s-ketamina, sal de (r)-csa de s-ketamina y procesos para la preparación de s-ketamina (divisional solicitud 201702854) | |
| EA201891910A1 (ru) | Гетероарильные ингибиторы pad4 | |
| EA201790764A1 (ru) | Новые соединения карбоновых кислот, подходящие для ингибирования микросомальной простагландин-e2-синтазы 1 | |
| MX374605B (es) | Compuestos inhibidores de jak quinasa para el tratamiento de enfermedad respiratoria. | |
| EP3263132C0 (en) | Composition for treating il-6-related diseases | |
| EA201791874A1 (ru) | Фторированные ингибиторы лизилоксидазоподобного фермента-2 и их применение | |
| BR112019003731A2 (pt) | aplicação de pridopidina para tratamento de distonias | |
| EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
| EA201791095A1 (ru) | Способ лечения рака | |
| CR20160582A (es) | Composición para tratar diabetes, que contienen un conjugado de análogo de insulina de acción prolongada y un conjugado de péptido insulinotrópico de acción prolongada | |
| CL2018000688A1 (es) | Compuestos heterociclicos que contienen bencilamina y composiciones útiles contra infección por micobacterias | |
| UY37017A (es) | Inhibidores aza-bencimidazol de pad4 | |
| EA201890567A1 (ru) | Способ лечения рака | |
| ECSP19057403A (es) | Usos terapéuticos de un polvo de insectos | |
| DOP2016000253A (es) | Nuevos compuestos | |
| JOP20190262B1 (ar) | مثبطات بيرازول magl | |
| EA201890810A1 (ru) | Соединения, эффективные для лечения гепатотоксичности и стеатоза печени, и их применение | |
| EP3630102A4 (en) | FORMULATIONS FOR THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER | |
| EA201591365A1 (ru) | Способ обработки волос | |
| MX394123B (es) | Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos | |
| EA202091259A1 (ru) | Способ получения опикапона и его интермедиатов | |
| MX2017001352A (es) | Derivados de pirrolidinona como inhibidores de metionina aminopeptidasa 2 (metap-2). | |
| EA201792610A1 (ru) | Способ лечения неврологического заболевания |